ASLAN Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update
SINGAPORE, July 13, 2020 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage immunology and oncology focused biopharmaceutical company developing […]